Organogenesis Holdings Inc. 8-K

What Happened

• Organogenesis Holdings Inc. announced its financial results for the fiscal fourth quarter and fiscal year ended December 31, 2025 via a press release dated February 26, 2026. The company furnished that press release to the SEC as Exhibit 99.1 in an 8-K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date of announcement: February 26, 2026.
• Period covered: fiscal fourth quarter and full year ended December 31, 2025.
• Filing note: the press release is furnished (Exhibit 99.1) and is stated not to be “filed” for purposes of Section 18 of the Exchange Act.
• Technical exhibit: the filing also references the Inline XBRL cover page interactive data file (Exhibit 104).

Why It Matters

• This 8‑K signals that Organogenesis has publicly released its quarterly and annual earnings information, which can include revenue, profit/loss, and other operating metrics that investors use to evaluate company performance. Because the 8‑K furnishes the press release rather than filing it, investors should review the attached Exhibit 99.1 and any related earnings materials or investor presentation for the specific financial figures and management commentary before making investment decisions.